• Academy Chapters
  • Psychiatry Studio
  • CME Academy
  • Blog
  • Pricing
  • Contact Us
    • Reviews
    Sign in

    Tag: Alzheimer’s Disease

    Geriatric Psychiatry Update: ChEIs for Psychotic Symptoms

    According to this recent meta-analysis published in JAMA Neurology on June 26, 2023: Cholinesterase Inhibitors treatment improves psychotic symptoms in patients with Alzheimer’s disease &…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh August 5, 2023

    Apathy in Alzheimer’s Disease: Basics & Beyond

    PSYCHIATRY EDUCATION FORUM ACADEMY’S APATHY IN ALZHEIMER’S DISEASE BASICS & BEYOND Alzheimer’s disease, a progressive neurodegenerative disorder, not only affects memory and cognitive functions but…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh July 15, 2023

    Lecanemab: FDA Approved for Early Alzheimer’s Disease

    On July 06, 2023: FDA announced the approval of Leqembi (Lecanemab) for adult patients with early Alzheimer’s Disease or mild cognitive impairment. Psychiatry Education Forum…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh July 8, 2023

    First FDA Approved Medication for Agitation Associated with Alzheimer’s Dementia

    On May 11, 2023: FDA announced the approval of Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer’s disease. This is the…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh May 16, 2023

    First Weekly Transdermal Patch Approved for Alzheimer’s Dementia: ADLARITY

    On March 14, 2022: FDA has approved the first and only once-weekly transdermal patch for Alzheimer’s dementia: Adlarity (Donepezil). Psychiatry Education Forum Academy has summarized…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh March 19, 2022

    How to Evaluate Six Neurocognitive Domains in Dementia? [PUBLISHED]

    Psychiatry Education Forum Academy published its next discussion series today: It is important to have knowledge of these six neuro-cognitive domains for the evaluation &…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh July 24, 2021

    Alzheimer’s Disease: Comparing FDA Approved Medications

    Alzheimer’s disease is the most common type/cause of dementia. As we know that FDA recently approved Aducanumab (Aduhelm) for the treatment of Alzheimer’s Disease (read…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh June 28, 2021

    Aducanumab: New Medication FDA Approved for Alzheimer’s Disease

    June 07, 2021 Today FDA has approved Aducanumab (Aduhelm) for the treatment of Alzheimer’s Disease. This is the first novel treatment to target the underlying…

    drharvinder206gmail-com-2
    Dr. Harvinder Singh June 7, 2021

    Join Academy Membership

    CME Academy

    Most Recent Posts

    • Treating Pediatric Mania: Which Medications Reduce Symptoms Most Effectively? July 5, 2025
    • Can Cariprazine Help with Anxious Depression? July 4, 2025
    • Using the Pomodoro Method to Manage ADHD: A Simple Yet Powerful Strategy June 24, 2025
    • Sulforaphane for Negative Symptoms of Schizophrenia June 15, 2025
    • Low Dose Naltrexone for MDD Augmentation: What Clinicians Should Know June 14, 2025
    • Ranking Antidepressants for Adolescent Depression Based on New Meta-Analysis May 31, 2025
    • How to Diagnose Prescription Benzodiazepine Physical Dependence? May 24, 2025
    • Understanding Hoover Test: to Differentiate Functional vs. Organic Limb Weakness April 26, 2025
    • Severe Melancholic Depression: Diagnose & Treatment Options April 16, 2025
    • Antipsychotics-Induced Akathisia: 6 Evidence-Based Treatment Options March 29, 2025
    • Brexpiprazole + Sertraline: Could this be the next FDA-approved treatment for PTSD? March 3, 2025
    • Maintenance Treatment in Bipolar Depression: What Recent Data Reveals March 1, 2025
    • FDA Eliminates Clozapine REMS Program: What This Means for Patients and Prescribers February 25, 2025

    Please note that this website is for educational purposes only and do refer to sources cited at the end of each topics for more information. Psychiatry Education Forum and authors do not assume any liability or responsibility for damage, injury, or death to you, other persons or property from any use of any ideas, information, or instruction in this website.

    Psychiatry Education Forum
    © 2025 - Psychiatry Education Forum   DISCLAIMER: Please note that this website is for educational purposes only and do refer to sources cited at the end of each topic for more information. Psychiatry Education Forum and authors do not assume any liability or responsibility for damage, injury, or death to you, other persons, or property from any use of any ideas, information, or instruction in this website.

    Report

    There was a problem reporting this post.

    Harassment or bullying behavior
    Contains mature or sensitive content
    Contains misleading or false information
    Contains abusive or derogatory content
    Contains spam, fake content or potential malware

    Block Member?

    Please confirm you want to block this member.

    You will no longer be able to:

    • Mention this member in posts
    • Message this member
    • Add this member as a connection

    Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

    Report

    You have already reported this .